Skip to main content
. 2021 Mar 4;16(3):e0247358. doi: 10.1371/journal.pone.0247358

Table 2. Absolute risks of major bleeding in selected patient sub groups (crude incidence rate per 1,000 patient-years, available case analysis).

Variable Incidence rate (95% CI)
Overall 10.6 (9.7–11.7)
Age 80+ 27.2 (21.1–35.0)
Chronic kidney disease 25.6 (20.8–31.6)
Low bodyweight (< 60 kg) 23.7 (17.3–32.4)
Prior stroke 18.9 (13.2–27.0)
Diabetes mellitus 16.8 (13.6–20.7)
Prior CABG 16.1 (12.0–21.7)
Female sex 14.9 (12.8–17.5)
Stent length ≥ 40 mm 13.0 (10.7–15.7)
Number of stents ≥ 3 12.8 (10.3–15.9)
Multivessel disease 12.7 (11.1–14.5)
Hypertension 12.7 (11.1–14.5)
Stent diameter < 3 mm 12.0 (10.3–14.0)
Prior MI 11.9 (9.0–15.7)
Current ACS 10.6 (9.5–11.8)
Hyperlipidemia 10.4 (9.1–11.8)

ACS: Acute coronary syndrome, CABG: Coronary artery bypass graft, CKD: Chronic kidney disease, MI: Myocardial infarction.